Clinical trials
Active, not recruiting Observational trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
491 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 7 |
| 2016 | 8 |
| 2017 | 8 |
| 2018 | 13 |
| 2019 | 15 |
| 2020 | 16 |
| 2021 | 23 |
| 2022 | 38 |
| 2023 | 66 |
| 2024 | 113 |
| 2025 | 117 |
| 2026 | 54 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 491 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 13 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 12 |
| Peking Union Medical College Hospital | 11 |
| Ruijin Hospital | 11 |
| Dong Peng | 10 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 10 |
| AstraZeneca | 9 |
| Peking University People's Hospital | 9 |
| First Affiliated Hospital of Chongqing Medical University | 7 |
| Sun Yat-sen University | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 18 |
| Breast Neoplasms | 17 |
| Carcinoma, Hepatocellular | 14 |
| Lung Neoplasms | 13 |
| Obesity | 12 |
| Colorectal Neoplasms | 10 |
| Stomach Neoplasms | 10 |
| Coronary Artery Disease | 9 |
| Neoplasms | 9 |
| Overweight | 9 |
Trials
Showing 1 to 25 of 491. Each trial links to its page on Pharma Observatory.
391 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.